{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:30:09Z","timestamp":1787797809983,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100031904","name":"ArcelorMittal Dofasco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jgo.2025.102846","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T13:10:53Z","timestamp":1769433053000},"page":"102846","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review of frailty, functional status &amp; comorbidities in older adults with multiple myeloma undergoing high dose therapy &amp; autologous stem cell transplant"],"prefix":"10.1016","volume":"17","author":[{"given":"Nadine","family":"Abdallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlyn","family":"O\u2019Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sikander","family":"Ailawadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Rosko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2025.102846_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000539225","article-title":"Historical perspective of high-dose therapy followed by autologous stem cell transplantation in multiple myeloma","author":"Cohen","year":"2024","journal-title":"Acta Haematol"},{"issue":"21","key":"10.1016\/j.jgo.2025.102846_bb0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1182\/blood.V120.21.596.596","article-title":"Trends in utilization and outcomes of autologous hematopoietic cell transplantation (AHCT) in the upfront management of Patients with multiple myeloma: a Cibmtr analysis","volume":"120","author":"Costa","year":"2012","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jgo.2025.102846_bb0015","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.18.02096","article-title":"Treatment of multiple myeloma: ASCO and CCO joint clinical practice guideline","volume":"37","author":"Mikhael","year":"2019","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jgo.2025.102846_bb0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ajh.25797","article-title":"Transplant eligibility in elderly multiple myeloma patients: prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65-75years","volume":"95","author":"Belotti","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jgo.2025.102846_bb0030","author":"National Comprehensive Cancer Network"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0035","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jgo.2019.05.014","article-title":"Autologous stem cell transplant in older patients (age\u00a0>\/=\u00a065) with newly diagnosed multiple myeloma: a systematic review and meta-analysis","volume":"11","author":"Mian","year":"2020","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13643-020-01542-z","article-title":"PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews","volume":"10","author":"Rethlefsen","year":"2021","journal-title":"Syst Rev"},{"key":"10.1016\/j.jgo.2025.102846_bb0045","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0050","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1002\/ajh.25310","article-title":"Melphalan-based autologous transplant in octogenarian multiple myeloma patients","volume":"94","author":"Saini","year":"2019","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1016\/j.jgo.2025.102846_bb0055","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/cncr.33171","article-title":"Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma","volume":"126","author":"Munshi","year":"2020","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.jgo.2025.102846_bb0060","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41375-019-0595-5","article-title":"The relative importance of factors predicting outcome for myeloma patients at different ages: results from 3894 patients in the myeloma XI trial","volume":"34","author":"Pawlyn","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.jgo.2025.102846_bb0065","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.bbmt.2014.07.013","article-title":"Older patients with myeloma derive similar benefit from autologous transplantation","volume":"20","author":"Sharma","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5144\/1658-3876.2011.30","article-title":"Age at transplantation and outcome after autologous stem cell transplantation in elderly patients with multiple myeloma","volume":"4","author":"El Cheikh","year":"2011","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"4","key":"10.1016\/j.jgo.2025.102846_bb0075","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/ejh.13922","article-title":"Tandem autologous stem cell transplantation in elderly patients with myeloma: a multicenter retrospective analysis","volume":"110","author":"Suzuki","year":"2023","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0080","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1200\/JOP.19.00208","article-title":"Integrating touchscreen-based geriatric assessment and frailty screening for adults with multiple myeloma to drive personalized treatment decisions","volume":"16","author":"Nathwani","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0085","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/jgs.15715","article-title":"Geriatric assessment in older adults with multiple myeloma","volume":"67","author":"Wildes","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"Suppl. 6","key":"10.1016\/j.jgo.2025.102846_bb0090","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.htct.2023.07.012","article-title":"Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study","volume":"46","author":"Seehaus","year":"2024","journal-title":"Hematol Transfus Cell Ther"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0095","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41409-020-01159-9","article-title":"Autologous stem cell transplantation for multiple myeloma patients aged >\/= 75 treated with novel agents","volume":"56","author":"Vaxman","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jgo.2025.102846_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00277-018-3528-x","article-title":"Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma","volume":"98","author":"Marini","year":"2019","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2169\/internalmedicine.52.8390","article-title":"Evaluation of the feasibility and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma","volume":"52","author":"Muta","year":"2013","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.jgo.2025.102846_bb0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/ejh.13357","article-title":"Autologous stem cell transplantation is safe in selected elderly multiple myeloma patients","volume":"104","author":"Antonioli","year":"2020","journal-title":"Eur J Haematol"},{"issue":"3","key":"10.1016\/j.jgo.2025.102846_bb0115","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/ejh.13804","article-title":"Autologous stem cell transplantation in multiple myeloma patients over 70 years: a GIMEMA Lazio working group experience in a retrospective case-control study","volume":"109","author":"Rago","year":"2022","journal-title":"Eur J Haematol"},{"issue":"14","key":"10.1016\/j.jgo.2025.102846_bb0120","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1080\/10428194.2019.1633633","article-title":"Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged >\/=75 years","volume":"60","author":"Bashir","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.jgo.2025.102846_bb0125","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3324\/haematol.2016.150334","article-title":"Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study","volume":"101","author":"Garderet","year":"2016","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bmt.1705580","article-title":"Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma","volume":"39","author":"Qazilbash","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3324\/haematol.2020.262360","article-title":"Autologous stem cell transplantation is safe and effective for fit, older myeloma patients: exploratory results from the myeloma XI trial","volume":"107","author":"Pawlyn","year":"2022","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.jgo.2025.102846_bb0140","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41409-019-0478-4","article-title":"Efficacy and safety of autologous stem cell transplantation in patients aged >\/= 65 years with multiple myeloma in the era of novel agents","volume":"54","author":"Mizuno","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jgo.2025.102846_bb0145","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bmt.2015.106","article-title":"High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma","volume":"50","author":"Wildes","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jgo.2025.102846_bb0150","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41409-020-01026-7","article-title":"Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma","volume":"56","author":"Lemieux","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"22","key":"10.1016\/j.jgo.2025.102846_bb0155","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1002\/cncr.33831","article-title":"Outcomes of upfront autologous hematopoietic cell transplantation in patients with multiple myeloma who are 75 years old or older","volume":"127","author":"Munshi","year":"2021","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jgo.2025.102846_bb0160","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/sj.bmt.1704288","article-title":"Autologous stem cell transplantation in multiple myeloma patients <60 vs >\/=60 years of age","volume":"32","author":"Reece","year":"2003","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jgo.2025.102846_bb0165","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4065\/83.10.1131","article-title":"Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative","volume":"83","author":"Gertz","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.jgo.2025.102846_bb0170","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.bbmt.2019.11.028","article-title":"Age is a prognostic factor for the overall survival of patients with multiple myeloma undergoing upfront autologous hematopoietic stem cell transplantation","volume":"26","author":"Cordas Dos Santos","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jgo.2025.102846_bb0175","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.bbmt.2013.12.557","article-title":"Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma","volume":"20","author":"Saad","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0180","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0185","doi-asserted-by":"crossref","first-page":"201","DOI":"10.14740\/jh1148","article-title":"The impact of renal impairment in multiple myeloma patients undergoing autologous stem cell transplantation with Melphalan conditioning","volume":"12","author":"Ursu","year":"2023","journal-title":"J Hematol"},{"issue":"9","key":"10.1016\/j.jgo.2025.102846_bb0190","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/bcj.2011.34","article-title":"Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM\u2013comorbidity score","volume":"1","author":"Kleber","year":"2011","journal-title":"Blood Cancer J"},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0195","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3324\/haematol.2016.162693","article-title":"A concise revised myeloma comorbidity index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients","volume":"102","author":"Engelhardt","year":"2017","journal-title":"Haematologica"},{"issue":"Supplement 1","key":"10.1016\/j.jgo.2025.102846_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/blood-2024-194414","article-title":"The composite health risk assessment model (CHARM) predicts risks of toxicities, functional and cognitive decline among survivors of allogeneic hematopoietic cell transplantation (Allo-HCT): a prospective BMT-CTN study 1704","volume":"144","author":"Sorror","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jgo.2025.102846_bb0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41408-022-00779-2","article-title":"The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review","volume":"13","author":"Mian","year":"2023","journal-title":"Blood Cancer J"},{"issue":"4","key":"10.1016\/j.jgo.2025.102846_bb0210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2019000758","article-title":"Gait speed, grip strength, and clinical outcomes in older patients with hematologic malignancies","volume":"134","author":"Liu","year":"2019","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.jgo.2025.102846_bb0215","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1200\/JCO.21.00118","article-title":"Models of care in geriatric oncology","volume":"39","author":"Chapman","year":"2021","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.jgo.2025.102846_bb0220","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2666-7568(21)00182-3","article-title":"Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings","volume":"2","author":"Soto-Perez-de-Celis","year":"2021","journal-title":"Lancet Healthy Longev"},{"issue":"22","key":"10.1016\/j.jgo.2025.102846_bb0225","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"issue":"16_suppl","key":"10.1016\/j.jgo.2025.102846_bb0230","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.TPS1661","article-title":"Practical geriatric assessment (PGA) implementation strategies and correlative evaluations (PACE-70): a hybrid implementation-effectiveness study in 3 community practices","volume":"43","author":"Aleixo","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2025.102846_bb0235","unstructured":"Mohyuddin, G.R., R. Chakraborty, K. Berger, R. Winborg, M.S. Barnes, J.A.H. Martinez, et al., Patient preferences on clinical decision making in multiple myeloma. JCO Oncol Pract. 0(0): p. OP-25-00322."},{"issue":"5","key":"10.1016\/j.jgo.2025.102846_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgo.2024.101781","article-title":"Understanding health outcome preferences of older adults diagnosed with multiple myeloma","volume":"15","author":"Maheshwari","year":"2024","journal-title":"J Geriatr Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.jgo.2025.102846_bb0245","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1182\/blood-2024-210334","article-title":"Real-world evidence for autologous stem cell transplantation in elderly multiple myeloma patients","volume":"144","author":"Kort","year":"2024","journal-title":"Blood"},{"issue":"Supplement_1","key":"10.1016\/j.jgo.2025.102846_bb0250","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1182\/blood-2019-130689","article-title":"Utilization of autologous stem cell transplantation in older patients with newly diagnosed multiple myeloma","volume":"134","author":"King","year":"2019","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.jgo.2025.102846_bb0255","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jgo.2025.102846_bb0260","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41409-021-01295-w","article-title":"Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78","volume":"56","author":"Fiala","year":"2021","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406825006629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:37:52Z","timestamp":1774057072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406825006629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1879406825006629"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102846","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of frailty, functional status & comorbidities in older adults with multiple myeloma undergoing high dose therapy & autologous stem cell transplant","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2025.102846","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102846"}}